STAAR Surgical Co. (STAA)

34.93
0.22 0.63
NASDAQ : Health Technology
Prev Close 34.71
Open 34.85
Day Low/High 34.77 / 35.03
52 Wk Low/High 21.70 / 41.65
Volume 61.60K
Avg Volume 328.00K
Exchange NASDAQ
Shares Outstanding 44.54M
Market Cap 1.53B
EPS 0.10
P/E Ratio 214.56
Div & Yield N.A. (N.A)

Latest News

STAAR Surgical To Host Investor And Analyst Day On November 8, 2019

STAAR Surgical To Host Investor And Analyst Day On November 8, 2019

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, announced today that the Company will host an Investor and Analyst Day on Friday, November 8, 2019 in...

STAAR Surgical Reports Third Quarter Results

STAAR Surgical Reports Third Quarter Results

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the third quarter ended September 27, 2019.

Interesting STAA Put And Call Options For June 2020

Interesting STAA Put And Call Options For June 2020

Investors in Staar Surgical Co. saw new options begin trading this week, for the June 2020 expiration.

Jannik Jorgensen, A Prospective Eye Surgeon And Passionate Sports Enthusiast, Received His EVO Visian ICLs In September 2019. (Photo: Business Wire)

Jannik Jorgensen, A Prospective Eye Surgeon And Passionate Sports Enthusiast, Received His EVO Visian ICLs In September 2019. (Photo: Business Wire)

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that Dr.

STAAR Surgical To Report Third Quarter Results On October 30, 2019

STAAR Surgical To Report Third Quarter Results On October 30, 2019

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the third quarter ended September 27, 2019...

Staar Surgical Becomes Oversold (STAA)

Staar Surgical Becomes Oversold (STAA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

STAAR Surgical Announces EVO ICL Clinical Program For Its 16th Annual Surgical Experts Summit In Paris, France From September 11 - 13, 2019

STAAR Surgical Announces EVO ICL Clinical Program For Its 16th Annual Surgical Experts Summit In Paris, France From September 11 - 13, 2019

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, is today announcing the EVO ICL Clinical Program which will be presented by Ophthalmic Surgeons to...

Asian Eye Institute, Rockwell Clinic Location. (Photo: Business Wire)

Asian Eye Institute, Rockwell Clinic Location. (Photo: Business Wire)

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it has entered a strategic alliance with Asian Eye Institute, an eye care group...

STAAR Surgical Announces FDA IDE Clinical Study Approval

STAAR Surgical Announces FDA IDE Clinical Study Approval

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, is today announcing that the FDA in a letter dated August 23, 2019, stated that it has determined that...

STAAR Surgical Announces Submission Of Presbyopia Clinical Trial Data; Proprietary EDOF Collamer® Lens Is Designed To Improve Near, Intermediate And Distance Vision

STAAR Surgical Announces Submission Of Presbyopia Clinical Trial Data; Proprietary EDOF Collamer® Lens Is Designed To Improve Near, Intermediate And Distance Vision

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced the submission of its multi-site European pivotal clinical trial data for the EVO+...

STAAR Surgical Reports Record Second Quarter Results For Total Revenue, ICL Sales And ICL Units

STAAR Surgical Reports Record Second Quarter Results For Total Revenue, ICL Sales And ICL Units

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the second quarter ended June 28, 2019.

STAAR Surgical To Report Second Quarter Results On July 31, 2019

STAAR Surgical To Report Second Quarter Results On July 31, 2019

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the second quarter ended June 28, 2019 on...

Noteworthy Tuesday Option Activity: STAA, NR, CVX

Noteworthy Tuesday Option Activity: STAA, NR, CVX

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Staar Surgical Co. , where a total of 2,367 contracts have traded so far, representing approximately 236,700 underlying shares.

Noteworthy Tuesday Option Activity: STAA, ACAD, PETS

Noteworthy Tuesday Option Activity: STAA, ACAD, PETS

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Staar Surgical Co. , where a total volume of 4,067 contracts has been traded thus far today, a contract volume which is representative of approximately 406,700 underlying shares (given that every 1 contract represents 100 underlying shares).

Staar Surgical Becomes Oversold (STAA)

Staar Surgical Becomes Oversold (STAA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Staar Surgical Becomes Oversold (STAA)

Staar Surgical Becomes Oversold (STAA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

STAAR Surgical Announces Expanded Recommended Diopter Range For EVO Visian ICL By Refractive Societies In Germany And Japan

STAAR Surgical Announces Expanded Recommended Diopter Range For EVO Visian ICL By Refractive Societies In Germany And Japan

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced the leading refractive ophthalmic societies in Germany and Japan have increased the...

STAAR Surgical Reports First Quarter Results

STAAR Surgical Reports First Quarter Results

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the first quarter ended March 29, 2019.

STAAR Surgical Celebrates One Million Lens Milestone For Implantable Collamer® Lens (ICL)

STAAR Surgical Celebrates One Million Lens Milestone For Implantable Collamer® Lens (ICL)

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer, and marketer of implantable lenses and companion delivery systems for the eye, today announced that more than one million Visian implantable Collamer lenses (ICLs) have been...

STAAR Surgical To Report First Quarter Results On May 1, 2019

STAAR Surgical To Report First Quarter Results On May 1, 2019

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the first quarter ended March 29, 2019 on...

Interesting STAA Put And Call Options For May 17th

Interesting STAA Put And Call Options For May 17th

Investors in Staar Surgical Co. saw new options begin trading this week, for the May 17th expiration.

STAAR Surgical Announces Strategic Cooperation Agreement With Vista Oftalmólogos

STAAR Surgical Announces Strategic Cooperation Agreement With Vista Oftalmólogos

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced a Strategic Cooperation Agreement with Vista Oftalmólogos, a 49-clinic ophthalmology...

STAAR Surgical Reports Fourth Quarter And Full Year 2018 Results

STAAR Surgical Reports Fourth Quarter And Full Year 2018 Results

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the fourth quarter and full year ended December 28, 2018.

STAAR Surgical Announces Strategic Cooperation Agreement With The Smile Eyes Group In Germany And Austria

STAAR Surgical Announces Strategic Cooperation Agreement With The Smile Eyes Group In Germany And Austria

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced a Strategic Cooperation Agreement with the Smile Eyes Group, an alliance of more than...

STAAR Surgical To Report Fourth Quarter Results On February 21, 2019

STAAR Surgical To Report Fourth Quarter Results On February 21, 2019

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the fourth quarter and fiscal year ended...

State Street Is Heading Downhill, Plus 4 Other Stocks That Look Good Short

STT, EDU, STAA, CVX and POL were all recently downgraded by TheStreet's Quant Ratings service.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: OCSI Downgrades: CIEN, CIR, CORE, EBIX, EFII, KOS, LMNX, LOB, SPAR, SRCI, STAA, VEC Initiations: CCT, CEIX Read on to get TheStreet Quant Ratings' detailed report:

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AAME, AYX, CRUS, FG, MUR, OHI, OTIV, SINO, STAA Downgrades: ABB, ANDE, ATVI, BDC, DVA, EGN, GAIA, GCI, LBTYA, LBTYB, LBTYK, MYE, MYGN, OSUR, PAR, SMG, SSB, TISI, VAC Initiations: ANGI, JBGS, PQG, ROKU Read on to get TheStreet Quant Ratings' detailed report:

TheStreet Quant Rating: C+ (Hold)